Iliocaval and iliofemoral venous stenting for obstruction secondary to tumor compression Journal Article
| Authors: | Aly, A. K.; Moussa, A. M.; Chevallier, O.; Kishore, S.; Petre, E.; Friedman, A.; Bryce, Y.; Gonzalez, A.; Camacho, J.; Santos, E.; Ridouani, F. |
| Article Title: | Iliocaval and iliofemoral venous stenting for obstruction secondary to tumor compression |
| Abstract: | Background: Cancer patients with pelviabdominal masses can suffer from lower extremity symptoms due to venous compression. The effectiveness of venous stenting has been established in extrinsic venous compression in benign conditions like May-Thurner syndrome. In this retrospective study we evaluate the efficacy and safety of caval, iliocaval and iliofemoral venous stenting for cases of extrinsic venous compression caused by malignant masses in cancer patients. Methods: IRB-approved retrospective review of patients who underwent iliofemoral venography with venoplasty and stenting between January 2018 and February 2022 was performed. Patients with extrinsic venous compression caused by malignant masses were included. Data on patient demographics, pre-procedure symptoms, procedural technique, stent characteristics, outcomes and follow-up were collected. Descriptive statistics were used to assess technical success, clinical success, primary stent patency and adverse events of the procedure. Results: Thirty-seven patients (19 males, 18 females) who underwent 45 procedures were included. Deep venous thrombosis (DVT) was present in 21 (57%) patients. Twenty-nine patients (78%, 95% CI 62–90%) reported clinical improvement of the presenting symptoms. The median overall survival after the procedure was 4.7 months (95% CI 3.58–5.99). Eight (22%) patients were alive at last follow up with median follow up of 10.33 months (Range 2–25 months). Twenty-six patients had patent stents on their last follow up imaging (70%, 95% CI 61%-91%). Two patients had a small access site hematoma which resolved spontaneously. Two patients developed moderate, and 1 patient developed severe adverse events related to post procedure therapeutic anticoagulation. Conclusion: Venous stenting is a safe procedure and should be considered as part of the palliative care for patients with debilitating lower extremity symptoms related to iliocaval and iliofemoral venous compression. Graphical Abstract: (Figure presented.) © The Author(s) 2024. |
| Keywords: | adult; clinical article; controlled study; human tissue; middle aged; overall survival; cancer patient; follow up; neoplasm; deep vein thrombosis; retrospective study; heparin; compression; anticoagulation; enoxaparin; adverse event; clinical outcome; epidural hematoma; vein occlusion; phlebography; mechanical thrombectomy; cancer; human; male; female; article; muscle hematoma; venous stenting; deep venous obstruction; venous compression |
| Journal Title: | CVIR Endovascular |
| Volume: | 7 |
| ISSN: | 2520-8934 |
| Publisher: | Springer Nature |
| Date Published: | 2024-12-01 |
| Start Page: | 33 |
| Language: | English |
| DOI: | 10.1186/s42155-024-00438-6 |
| PROVIDER: | scopus |
| PMCID: | PMC10957860 |
| PUBMED: | 38514484 |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work